These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors. Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT. Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337 [TBL] [Abstract][Full Text] [Related]
4. Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors. Yabe H; Yabe M; Hattori K; Hinohara T; Morimoto T; Nakamura Y; Noma M; Takei M; Kobayashi N; Tsuji K; Kato S Bone Marrow Transplant; 1996 Jun; 17(6):985-91. PubMed ID: 8807104 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation. Ayas M; Al-Jefri A; Al-Mahr M; Rifai S; Moussa E; Karaoui M; Roberts G; El-Solh H Bone Marrow Transplant; 2004 Jan; 33(1):15-7. PubMed ID: 14578932 [TBL] [Abstract][Full Text] [Related]
6. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies. Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507 [TBL] [Abstract][Full Text] [Related]
7. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Chaudhury S; Auerbach AD; Kernan NA; Small TN; Prockop SE; Scaradavou A; Heller G; Wolden S; O'Reilly RJ; Boulad F Br J Haematol; 2008 Mar; 140(6):644-55. PubMed ID: 18302713 [TBL] [Abstract][Full Text] [Related]
8. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD. Levine JE; Wiley J; Kletzel M; Yanik G; Hutchinson RJ; Koehler M; Neudorf S Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008 [TBL] [Abstract][Full Text] [Related]
9. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Handgretinger R; Klingebiel T; Lang P; Schumm M; Neu S; Geiselhart A; Bader P; Schlegel PG; Greil J; Stachel D; Herzog RJ; Niethammer D Bone Marrow Transplant; 2001 Apr; 27(8):777-83. PubMed ID: 11477433 [TBL] [Abstract][Full Text] [Related]
10. Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia. Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schauenstein K; Schumm M; Handgretinger R Bone Marrow Transplant; 2000 Mar; 25(5):513-7. PubMed ID: 10713628 [TBL] [Abstract][Full Text] [Related]
11. [Infantile T cell acute lymphoblastic leukemia complicated by thrombotic microangiopathy and human herpes virus 6 infection after allogeneic peripheral blood stem cell transplantation using CD34-positive cells]. Hasegawa D; Sano K; Kosaka Y; Hayakawa A; Kawagoe R; Amo K; Taya K; Hirabayashi N; Nakamura H Rinsho Ketsueki; 1999 Jul; 40(7):574-80. PubMed ID: 10483141 [TBL] [Abstract][Full Text] [Related]
12. [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation]. Wu B; Guo K; Song Z; Yan D; Yang Y; Xiao L Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):194-7. PubMed ID: 12133456 [TBL] [Abstract][Full Text] [Related]
13. Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation. Ferrá C; Rodríguez-Luaces M; Gallardo D; Encuentra M; Martín-Henao GA; Peris J; Ancín I; Sarrá J; Berlanga JJ; García J; Grañena A Bone Marrow Transplant; 2001 Nov; 28(10):963-8. PubMed ID: 11753552 [TBL] [Abstract][Full Text] [Related]
14. Transplantation of related and unrelated umbilical cord blood stem cells in Austria. Austrian Working Party for Stem Cell Transplantation. Austrian Society of Hematology and Oncology. Schwinger W; Urban C; Lackner H; Kerbl R; Sovinz P; Gardner H; Peters C; Niederwieser D; Fink FM; Kögler G Wien Klin Wochenschr; 1999 May; 111(9):348-53. PubMed ID: 10407995 [TBL] [Abstract][Full Text] [Related]
15. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation. Strober S Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036 [TBL] [Abstract][Full Text] [Related]
16. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease. Huang XJ; Han W; Xu LP; Chen YH; Liu DH; Lu J; Chen H; Zhang YC; Jiang Q; Liu KY; Lu DP Chin Med J (Engl); 2004 Dec; 117(12):1778-85. PubMed ID: 15603704 [TBL] [Abstract][Full Text] [Related]
17. Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias. Bunin N; Aplenc R; Grupp S; Pierson G; Monos D Bone Marrow Transplant; 2006 Jan; 37(2):143-9. PubMed ID: 16284615 [TBL] [Abstract][Full Text] [Related]
18. [Transplantation of highly purified CD34+ hematologic peripheral stem cells from haploidentical related donors in the treatment of children with non-malignant diseases]. Starý J; Sedlácek P; Vodvárková S; Poloucková A; Formánková R; Gasová Z; Marinov I Cas Lek Cesk; 2002 Mar; 141(6):176-81. PubMed ID: 11977835 [TBL] [Abstract][Full Text] [Related]
19. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation. Abu-Ghosh A; Goldman S; Slone V; van de Ven C; Suen Y; Murphy L; Sender L; Cairo M Bone Marrow Transplant; 1999 Sep; 24(5):535-44. PubMed ID: 10482939 [TBL] [Abstract][Full Text] [Related]
20. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]